Immune Support Peptides: Thymosin & Immune Modulation Research
Immune-modulating peptides include Thymosin Alpha-1, which has regulatory approval in several countries outside the US for hepatitis B and C and as an immune adjuvant. This category encompasses peptides studied for their potential to modulate immune system function, enhance immune surveillance, and support immune recovery. Evidence quality varies from robust clinical data (Thymosin Alpha-1) to preliminary preclinical research.
3 compounds in this category
TB-500Thymosin Beta-4, TB4
A naturally occurring peptide central to cell migration and tissue repair. Phase 2 human wound healing trials showed accelerated healing; also studied for cardiac and corneal repair.
SelankTP-7
A synthetic peptide analog of tuftsin, approved in Russia for anxiety and studied for nootropic and immunomodulatory properties.
Thymosin Alpha-1TĪ±1, Thymalfasin
A naturally occurring thymic peptide approved internationally for immune modulation, with extensive clinical data in hepatitis and cancer immunotherapy.